Related Experiment Videos
[Case example: malignant infantile osteopetrosis--pathogenesis and therapeutic options]
D K Stachel1, I Schmid, H Schmidt
1Dr. von Haunersches Kinderspital, München.
Klinische Padiatrie
|April 30, 1998
Summary
Malignant infantile osteopetrosis, a rare bone disorder, is diagnosed by excessive bone formation. Early bone marrow transplantation offers a cure, preventing irreversible nerve damage.
Area of Science:
- Pediatric Hematology/Oncology
- Skeletal Dysplasias
- Rare Genetic Diseases
Background:
- Malignant infantile osteopetrosis (MIOP) is a rare genetic disorder characterized by impaired osteoclast function.
- This leads to increased bone density (sclerosis) due to defective bone resorption, contrasting with normal bone formation.
- Clinical manifestations include bone fragility, pancytopenia, and neurological complications.
Observation:
- This case report details an infant diagnosed with malignant infantile osteopetrosis.
- The diagnosis was established through characteristic clinical and radiological findings.
- The infant presented with symptoms consistent with the pathophysiology of defective bone breakdown.
Findings:
- Early and accurate diagnosis of MIOP is crucial for timely intervention.
- Bone marrow transplantation (BMT) is the only established curative treatment for MIOP.
- Prompt BMT in infancy can reverse osteopetrotic symptoms and prevent severe complications like optic nerve compression.
Implications:
- Highlighting the critical importance of early diagnosis for effective treatment of MIOP.
- Emphasizing bone marrow transplantation as a life-saving intervention for affected infants.
- Underscoring the need for increased awareness among clinicians regarding this rare but treatable condition.